No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract CASTOR trial follow-up: Health-related quality of life was maintained in patients treated with daratumumab, bortezomib, and dexamethasone over time for relapsed or refractory multiple myeloma

byKathleen Lau

March 4, 2021

in StudyGraphics

#VisualAbstract: Higher metastatic lymph node burden is associated with worse overall survival in Merkel cell carcinoma

RelatedReports

Benefits of high-intensity surveillance following colorectal adenoma removal likely outweigh costs

Chronic Disease

The incidence of early-onset metastatic adenocarcinoma may be higher among patients with multiple metastatic sites and peritoneal involvement

April 30, 2026

Thoracic radiotherapy improves survival in small-cell lung cancer patients

Chronic Disease

Simvastatin (Zocor) in combination with paclitaxel (Taxol) may provide treatment benefit compared to paclitaxel alone for small cell lung cancer

April 15, 2026

Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization

Cardiology

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

April 9, 2026

Radiation plus hormone therapy may improve prostate cancer survival

Oncology

Pfizer’s Talzenna combo significantly delays prostate cancer progression

April 9, 2026

Galangin may sensitize apoptosis-resistant renal carcinoma cells [PreClinical]

Cabozantinib improves progression-free survival in patients with metastatic papillary renal cell carcinoma

#VisualAbstract: Cemiplimab monotherapy significantly improves outcomes in patients with advanced non-small-cell lung cancer with PD-L1 of at least 50%

#VisualAbstract: Relugolix combination therapy led to reduction in uterine fibroid symptoms

#VisualAbstract OAsIS: Ibrutinib, obinutuzumab, and venetoclax was well-tolerated and showed high response rates in both untreated and relapsed mantle cell lymphoma

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports